drugset / Trial / NCT00713323

A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain.

NCT00713323 ↗

Phase 3 Completed 380 enrolled Jazz Pharmaceuticals
NaSingle-groupOpen-labelSupportive care

Summary

The purpose of this study is to assess the safety and tolerability of long term therapy with Sativex® in relieving neuropathic pain.

Timeline

Start
2005-10
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject CBD Unknown 25 mg/ml —
Subject THC Unknown 27 mg/ml —

Indications